Is Moderna Stock a Buy?
Moderna (NASDAQ: MRNA) went from being an unknown biotech to a household name thanks to its work developing and marketing one of the most successful COVID-19 vaccines. Though the company has delivered outsize returns since late 2019, its shares are down more than 70% from their peak in 2021. Moderna's coronavirus-related revenue dropped off a cliff, dragging down its bottom line (and its stock price along with it). However, several developments may suggest that it is still worth investing in Moderna. Is the company doing enough to make its prospects attractive? Let's find out.
Source Fool.com
Moderna Inc. Stock
€111.38
-0.790%
With 18 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 129 € shows a slightly positive potential of 15.82% compared to the current price of 111.38 € for Moderna Inc..
